CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers.
about
Plasmacytoid dendritic cells: linking innate and adaptive immunityTransplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential StrategiesPlasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell TransplantationBone marrow cell graft engineering: from bench to bedside.Peripheral blood stem cell mobilization: new regimens, new cells, where do we standChemokine-mobilized adult stem cells; defining a better hematopoietic graft.Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacementUmbilical cord blood for allogeneic transplantation in children and adults.Novel regulatory therapies for prevention of Graft-versus-host disease.Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis.Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection.Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selectionThe role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftmentStem cell-based therapeutic applications in retinal degenerative diseases.Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice.Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftmentMesenchymal stem cells in immunoregulation.Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance.Plasmacytoid precursor dendritic cells from NOD mice exhibit impaired function: are they a component of diabetes pathogenesis?Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC.The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice.MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease?CD4 and CD8: an inside-out coreceptor model for innate immune cells.The biology of allogeneic hematopoietic cell resistanceEmerging uses for pediatric hematopoietic stem cells.Facilitating cells: Translation of hematopoietic chimerism to achieve clinical toleranceImpact of T cells on hematopoietic stem and progenitor cell function: Good guys or bad guys?Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides.Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin.Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.Niches for Hematopoietic Stem Cells and Their Progeny.
P2860
Q24558695-FD77CB77-4684-4067-BF16-20D102491DDAQ26752512-CFBD13E6-1F62-486A-8FFB-7E1649412EFFQ26773952-107E405E-063D-4815-BD9B-FE6218CA67DBQ28078949-2971140F-4C9D-40B9-9C1D-5EADFEA69ECCQ30666969-46CD7299-953E-4F1E-B4AB-8B3E263ADC29Q33589591-9E9C52B3-E2AA-4128-BB8E-5976608B6305Q33623545-6567CA6C-030C-4749-A8B6-C0796CE214D2Q33937966-1EFCDA6C-32C0-46B4-9512-A64777DA3759Q34021167-8D87A445-04DD-4A98-8A20-6B6056953B1DQ34178470-BA8852E0-E0DE-4A6F-816D-D9F9E312F468Q34269481-74918CB0-AC65-43F8-8185-1738F85B2A4AQ34616704-E44E0FA4-F590-4CB5-8D02-AFFA704780A9Q35083431-52F296ED-9E90-46A4-81F8-BB76D28CA5EEQ35191262-CB621AE0-DE99-4683-8067-0385B2F32EF8Q35208665-B2663BD7-94B2-4446-823C-7CE0D66ED4D2Q35603220-335BAA85-8083-4F43-A5AB-E412F6C43DBBQ35901690-EDFB3B80-A075-4AD9-AA45-9D7D1AA0591AQ36127641-DFA8BF40-A4A4-4EC1-ACCC-1F6366143C1AQ36161297-5307858E-1AE8-4340-8FD8-0E3C84A6D638Q36403190-08BD79CF-87EC-4625-A2C6-C0F6E28D209CQ36547852-BB71460E-03D0-4D67-B9B4-8818E0307320Q36752218-67CB7573-751E-46A6-A974-D2431423CFDDQ36842578-0A866759-D843-4056-8528-D355A70C9594Q36857931-9E5AE3BC-A3E1-45C4-A969-095D8E3F5690Q36951804-964AD550-0626-492E-86FE-0872B1352296Q37209033-F56BE53A-5E8C-4A21-8C0F-A66FE10FF586Q37262486-0BD304F6-42B0-4BDF-A95D-B0F8C08A6547Q37352764-ACBEA9EE-82FE-40E3-A03B-25EBD1FB00B1Q37463558-0543097D-A9B1-49DF-AF18-9C9CBE8949FCQ37632886-215325FC-731D-4687-A1A7-60A327D72F10Q37978779-24DF178F-E75E-4D40-A1BB-2EA7CCD85A22Q38690514-CF9D9827-53D1-46EE-85C5-EC92815C57C1Q39176779-8065901F-3E67-4385-BEF2-9B02AE76B6B4Q40183386-03EFA794-6E79-4F5B-BF29-933D719F8F35Q41996510-A1CE976F-4268-4929-BE9C-2AA7B0C3C017Q42226969-A1EE427D-DC89-4E18-A818-31D807ACDA64Q42659381-89CDCD01-DD92-47F3-B234-330BA4C7B7D4Q44139122-88E37777-F2AF-4E85-8089-C9AD48DDC98FQ44483603-B53FBEBE-A9FC-4D53-AD8B-59A301B0DCF3Q52317346-731956A3-7CC5-44B2-B528-01B8724BAA28
P2860
CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
CD8+TCR+ and CD8+TCR- cells in ...... ls across allogeneic barriers.
@en
type
label
CD8+TCR+ and CD8+TCR- cells in ...... ls across allogeneic barriers.
@en
prefLabel
CD8+TCR+ and CD8+TCR- cells in ...... ls across allogeneic barriers.
@en
P2093
P1433
P1476
CD8+TCR+ and CD8+TCR- cells in ...... ls across allogeneic barriers.
@en
P2093
P304
P356
10.1016/S1074-7613(00)80133-8
P407
P577
1999-11-01T00:00:00Z